Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $333.8600 (-1.54%) ($330.6910 - $339.9836) on Tue. Mar. 20, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.09% (three month average) | | RSI | 65 | | Latest Price | $333.8600(-1.54%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | | Weekly Trend | REGN advances 1.4% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | | Factors Impacting REGN price | REGN will decline at least -1.045% in a week (0% probabilities).
UUP(-10%) TLT(-7%) VIXM(-6%) TIP(-1%) SHY(-1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.045% (StdDev 2.09%) | | Hourly BBV | 0 () | | Intraday Trend | -1.4% | | | | | |
|
| 5 Day Moving Average | $338.52(-1.38%) | | 10 Day Moving Average | $339.14(-1.56%) | | 20 Day Moving Average | $332.23(0.49%) | | To recent high | -15.2% | | To recent low | 5.7% | | Market Cap | $35.399b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |